Lactulose, Rifaximin

Rifabiz L is first time in India combination of Lactulose, Rifaximin which is used in hepatic encephalopathy that is temporary neurological (nervous system) disorder due to chronic, severe liver disease.
A diseased liver struggles to filter toxins (substances created from the breakdown of food, alcohol, medications, and even muscle) from the bloodstream. These toxins build up in the body and travel to the brain. Toxicity affects brain function and causes cognitive impairment.
Lactulose is used in constipation and Hepatic encephalopathy. It may also be used to treat and prevent complications of liver disease (hepatic encephalopathy).
Rifaximin is an antibiotic, used to treat traveler’s diarrhea, irritable bowel syndrome, and hepatic encephalopathy. It acts only in the GI tract & thus has low systemic toxicity.

Therapy Area: Anti-infective and Anti-inflammatory
Form: Oral suspension
Packaging: 1 bottle


Lactulose 10gm, Rifaximin 400mg


Lactulose: decreases intestinal production and absorption of ammonia (Eliminate the toxic ammonia).

Rifaximin: Rifaximin reduces ammonia production by eliminating ammonia-producing colonic bacteria. It treats hepatic encephalopathy by stopping the growth of bacteria that produce toxins and that may worsen liver disease.

Indications Hepatic Encephalopathy


  • Hepatic Encephalopathy


15 ml TID or as directed by physician


This information is for registered medical practitioner only. Anyone other than medical practitioner should consult medical practitioner before using this product.

Enquire About Rifabiz L

Fill the form below and we will get in touch with you

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.